Sign In
test

Nicholas Boston

Highvista Strategies Llc

Assets Managed
$362.159M
Holdings
156
Last Quarter
2026 - Q1
Filed Date
1d ago
Growth Rate
-6.73%(2Q avg: -5.77%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 156 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 362.159M in assets, with a quarterly growth rate of -6.73% and a 2-quarter average growth rate of -5.77%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
DBC
Invesco Db Commodity Index T
Recent Activity
8.46%
$30.607M
1.057M shares@ $28.95 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 56.9%
3.49%
$12.611M
113,254 shares@ $111.36 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 1.87%
2.35%
$8.481M
26,323 shares@ $322.2 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Decreased -41.47%
2.1%
$7.584M
197,051 shares@ $38.5 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
Decreased -22.28%
2.04%
$7.378M
146,264 shares@ $50.44 avg price
PCVX
Vaxcyte Inc
Recent Activity
Increased 9.3%
2.01%
$7.243M
124,647 shares@ $58.11 avg price
RVMD
Revolution Medicines Inc
Recent Activity
Decreased -42.35%
1.87%
$6.74M
69,309 shares@ $97.26 avg price
TERN
Terns Pharmaceuticals Inc
Recent Activity
Decreased -34.85%
1.67%
$6.026M
114,307 shares@ $52.72 avg price
GPCR
Structure Therapeutics Inc
Recent Activity
Decreased -35.79%
1.65%
$5.972M
123,909 shares@ $48.21 avg price
NUVL
Nuvalent Inc-a
Recent Activity
Decreased -22.76%
1.61%
$5.799M
56,602 shares@ $102.45 avg price

1-10 of 156